Zhao Baiteng
SEC insider (Form 3/4/5 filer). CIK 0002049287. Director at Whitehawk Therapeutics, Inc. (WHWK). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in MORRISTOWN, NJ.
Companies Zhao Baiteng has filed insider reports for
- Whitehawk Therapeutics, Inc. (WHWK): Director
Zhao Baiteng
CIK: 0002049287
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Whitehawk Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 12, 2026WHWK
Whitehawk Therapeutics, Inc.
AwardDirectStock Option (right to buy)
38K shares- - Jun 17, 2025WHWK
Whitehawk Therapeutics, Inc.
AwardDirectStock Option (right to buy)
40K shares- - Mar 4, 2025AADI
Aadi Bioscience, Inc.
AwardIndirect1.3M shares at avg. $2.40$3.0M - Dec 19, 2024AADI
Aadi Bioscience, Inc.
AwardDirectStock Option (right to buy)
61.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award Stock Option (right to buy) | 38,040 | - | - | Direct |
| Jun 17, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award Stock Option (right to buy) | 40,006 | - | - | Direct |
| Mar 4, 2025 |  AADI Aadi Bioscience, Inc. | Award | 1,250,000 | $2.40 | $3,000,000 | Indirect |
| Dec 19, 2024 | AADI Aadi Bioscience, Inc. | Award Stock Option (right to buy) | 61,192 | - | - | Direct |
1-4 of 4 transactions